Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5-fluorouracil chemotherapy in the B16 melanoma model

Author:

Qu Xiaoyi,Felder Mildred A.R.,Perez Horta Zulmarie,Sondel Paul M.,Rakhmilevich Alexander L.

Funder

NIH-NCI

Midwest Athletes Against Childhood Cancer (MACC) Fund

The Crawdaddy Foundation

UW-Madison Hilldale Undergraduate Research Fellowship

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference30 articles.

1. Combinations of anticancer drugs and immunotherapy;Mitchell;Cancer Immunol Immunother,2003

2. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells;North;J Exp Med,1982

3. Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide;Lutsiak;Blood,2005

4. Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer;Solomayer;Clin Cancer Res,2003

5. Biology and clinical application of CD40 in cancer treatment;Fonsatti;Semin Oncol,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3